Additionally, TCA can activate hepatic stellate cells by upregulating the Toll-like receptor 4 (TLR4) signaling pathway, thereby playing an important role in both liver remodeling and the development of portal hypertension [46,53,54]. Here, TLR4 is linked to portal hypertension.